Executive Function in Learning in Children With Attention Deficit Hyperactivity Disorder (ADHD) Receiving Medical Treatment Alone Compared to Children Receiving Additional Treatment to Improve Learning Strategies
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01531127 |
Recruitment Status
: Unknown
Verified February 2012 by Hillel Yaffe Medical Center.
Recruitment status was: Not yet recruiting
First Posted
: February 10, 2012
Last Update Posted
: February 10, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
ADHD |
Study Type : | Observational |
Estimated Enrollment : | 30 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Study Start Date : | March 2012 |
Estimated Primary Completion Date : | March 2013 |
Estimated Study Completion Date : | March 2013 |
Group/Cohort |
---|
Combined Therapy
ADHD Medication and Learning Strategies Treatment
|
ADHD Medication Treatment
Control group
|
- Level of Executive Functioning [ Time Frame: One year ]Brief Behavior Rating Inventory of Executive Function will be administered

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 6 Years to 15 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Normal development for age
- ADHD
Exclusion Criteria:
- Low compliance
- Developmental delay
- Chronic disease

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01531127
Contact: Muhammad Mahajnah, MD, PhD | 972-506246959 | MohamedM@hy.health.gov.il |
Israel | |
Hillel Yaffe Medical Center | |
Hadera, Israel, 38100 |
Responsible Party: | Hillel Yaffe Medical Center |
ClinicalTrials.gov Identifier: | NCT01531127 History of Changes |
Other Study ID Numbers: |
0014-12-HYMC |
First Posted: | February 10, 2012 Key Record Dates |
Last Update Posted: | February 10, 2012 |
Last Verified: | February 2012 |
Additional relevant MeSH terms:
Attention Deficit Disorder with Hyperactivity Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders |